Animal to human translation: a systematic scoping review of reported concordance rates
CHC Leenaars, C Kouwenaar, FR Stafleu… - Journal of translational …, 2019 - Springer
Background Drug development is currently hampered by high attrition rates; many
developed treatments fail during clinical testing. Part of the attrition may be due to low …
developed treatments fail during clinical testing. Part of the attrition may be due to low …
Extrapolating from animals to humans
JPA Ioannidis - Science translational medicine, 2012 - science.org
Because of a variety of caveats, the safety and effectiveness of interventions in human
subjects can only be speculated from animal studies. Careful synthesis of data from multiple …
subjects can only be speculated from animal studies. Careful synthesis of data from multiple …
Translation of research evidence from animals to humans
DG Hackam, DA Redelmeier - Jama, 2006 - jamanetwork.com
Methods The 7 leading scientific journals by citation impact factor (Journal Citation Reports,
Thomson Scientific, Philadelphia, Pa, 2004) that regularly publish original animal studies …
Thomson Scientific, Philadelphia, Pa, 2004) that regularly publish original animal studies …
Poor translatability of biomedical research using animals—A narrative review
LJ Marshall, J Bailey, M Cassotta… - Alternatives to …, 2023 - journals.sagepub.com
The failure rate for the translation of drugs from animal testing to human treatments remains
at over 92%, where it has been for the past few decades. The majority of these failures are …
at over 92%, where it has been for the past few decades. The majority of these failures are …
Is it possible to overcome issues of external validity in preclinical animal research? Why most animal models are bound to fail
P Pound, M Ritskes-Hoitinga - Journal of translational medicine, 2018 - Springer
Background The pharmaceutical industry is in the midst of a productivity crisis and rates of
translation from bench to bedside are dismal. Patients are being let down by the current …
translation from bench to bedside are dismal. Patients are being let down by the current …
[HTML][HTML] Systematic reviews of preclinical animal studies can make significant contributions to health care and more transparent translational medicine
M Ritskes‐Hoitinga, M Leenaars, M Avey… - … of systematic reviews, 2014 - ncbi.nlm.nih.gov
Preclinical evidence, like clinical evidence, is used to inform decisions about the safety and
e icacy of treatments for participants in clinical trials.[1] Unlike clinical studies, most …
e icacy of treatments for participants in clinical trials.[1] Unlike clinical studies, most …
Progress in using systematic reviews of animal studies to improve translational research
CR Hooijmans, M Ritskes-Hoitinga - PLoS medicine, 2013 - journals.plos.org
Carlijn Hooijmans and colleagues discuss developments that might improve the quality and
translation of animal research, focusing on the importance of systematic reviews, the role of …
translation of animal research, focusing on the importance of systematic reviews, the role of …
Translation and back-translation methodology in health research–a critique
Introduction While back translation has been widely used in medical research surveying
linguistically diverse populations, research literature often fails to document this complex …
linguistically diverse populations, research literature often fails to document this complex …
Translational medicine: science or wishful thinking?
M Wehling - Journal of translational medicine, 2008 - Springer
Abstract" Translational medicine" as a fashionable term is being increasingly used to
describe the wish of biomedical researchers to ultimately help patients. Despite increased …
describe the wish of biomedical researchers to ultimately help patients. Despite increased …
[HTML][HTML] Animal models in translational medicine: Validation and prediction
T Denayer, T Stöhr, M Van Roy - New Horizons in Translational Medicine, 2014 - Elsevier
Despite large investments in drug development, the overall success rate of drugs during
clinical development remains low. One prominent explanation is flawed preclinical research …
clinical development remains low. One prominent explanation is flawed preclinical research …